136 related articles for article (PubMed ID: 37581651)
41. Prevalence and associations of central serous chorioretinopathy in elderly Chinese. The Beijing Eye Study 2011.
Li Y; You QS; Wei WB; Xu J; Chen CX; Wang YX; Xu L; Jonas JB
Acta Ophthalmol; 2016 Jun; 94(4):386-90. PubMed ID: 26928876
[TBL] [Abstract][Full Text] [Related]
42. BILATERAL SEROUS CHORIORETINOPATHY AND PIGMENTARY GLAUCOMA - WHAT IS THE ASSOCIATION?
Lešin Gaćina D; Jandroković S; Vidas Pauk S; Pupić-Bakrač A; Vukojević N; Petriček I; Škegro I; Galiot Delić M
Acta Clin Croat; 2022 Dec; 61(4):727-734. PubMed ID: 37868183
[TBL] [Abstract][Full Text] [Related]
43. Risk factors for central serous chorioretinopathy in pregnant Japanese women.
Morikawa M; Cho K; Kojima T; Chiba K; Ishikawa S; Umazume T; Nakagawa K; Yamada T; Yamada T; Minakami H
J Obstet Gynaecol Res; 2017 May; 43(5):866-872. PubMed ID: 28188952
[TBL] [Abstract][Full Text] [Related]
44. Migraine and increased risk of developing open angle glaucoma: a population-based cohort study.
Huang JY; Su CC; Wang TH; Tsai IJ
BMC Ophthalmol; 2019 Feb; 19(1):50. PubMed ID: 30760249
[TBL] [Abstract][Full Text] [Related]
45. OCT Risk Factors for 3-Year Development of Macular Complications in Eyes With "Resolved" Chronic Central Serous Chorioretinopathy.
Borrelli E; Battista M; Sacconi R; Gelormini F; Querques L; Grosso D; Vella G; Bandello F; Querques G
Am J Ophthalmol; 2021 Mar; 223():129-139. PubMed ID: 33342759
[TBL] [Abstract][Full Text] [Related]
46. Isolated pigment epithelium detachment: evidence for relation to central serous chorioretinopathy and effect of photodynamic therapy.
Arif F; Pryds A; Larsen M
Acta Ophthalmol; 2018 Dec; 96(8):821-827. PubMed ID: 30246489
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy.
Fok AC; Chan PP; Lam DS; Lai TY
Ophthalmic Res; 2011; 46(3):160-3. PubMed ID: 21389741
[TBL] [Abstract][Full Text] [Related]
48. Relationship between Using Fibrate and Open-Angle Glaucoma in Hyperlipidemic Patients: A Population-Based Cohort Study.
Tsai YE; Chen YH; Sun CA; Chung CH; Chien WC; Chien KH
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206602
[TBL] [Abstract][Full Text] [Related]
49. Biometric characteristics of eyes with central serous chorioretinopathy.
Oh JH; Oh J; Togloom A; Kim SW; Huh K
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
[TBL] [Abstract][Full Text] [Related]
50. Dysfunctional personality beliefs and psychopathology in patients with central serous chorioretinopathy.
Çam F; Sevik MO; Aykut A; Dericioğlu V; Şahin Çam C; Şahin Ö
J Fr Ophtalmol; 2024 Feb; 47(2):103997. PubMed ID: 37919151
[TBL] [Abstract][Full Text] [Related]
51. Increased risk of glaucoma amongst new-onset gout patients aged 20-39 years: A nationwide population-based cohort study in Taiwan.
Perng WT; Hung YM; Lai WY; Chu KA; Wang YH; Wei JC
Int J Clin Pract; 2021 Jul; 75(7):e14169. PubMed ID: 33788372
[TBL] [Abstract][Full Text] [Related]
52. Short axial length and hyperopic refractive error are risk factors of central serous chorioretinopathy.
Terao N; Koizumi H; Kojima K; Kusada N; Nagata K; Yamagishi T; Yoneda K; Yoshii K; Kinoshita S; Sotozono C
Br J Ophthalmol; 2020 Sep; 104(9):1260-1265. PubMed ID: 31780441
[TBL] [Abstract][Full Text] [Related]
53. Central Serous Chorioretinopathy in African Americans at Wilmer Eye Institute.
Mehta PH; Chhablani J; Wang J; Meyerle CB
J Natl Med Assoc; 2018 Jun; 110(3):297-302. PubMed ID: 29778134
[TBL] [Abstract][Full Text] [Related]
54. Retinal and choroidal vasoreactivity in central serous chorioretinopathy.
Penas S; Araújo T; Mendonça AM; Faria S; Silva J; Campilho A; Martins ML; Sousa V; Rocha-Sousa A; Carneiro Â; Falcão-Reis F
Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3825-3836. PubMed ID: 35838808
[TBL] [Abstract][Full Text] [Related]
55. Does Migraine Increase the Risk of Glaucoma?: A Population-Based Cohort Study.
Chen HY; Lin CL; Kao CH
Medicine (Baltimore); 2016 May; 95(19):e3670. PubMed ID: 27175700
[TBL] [Abstract][Full Text] [Related]
56. Association between atrial fibrillation and the risk of glaucoma development: a 12-year Nationwide cohort study.
Cho HK; Han JC; Choi JA; Chae JE; Kim RB
Eye (Lond); 2023 Jul; 37(10):2033-2041. PubMed ID: 36371604
[TBL] [Abstract][Full Text] [Related]
57. Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy.
Brinks J; van Dijk EHC; Tsonaka R; Meijer OC; Boon CJF
Ophthalmologica; 2022; 245(6):555-562. PubMed ID: 35843207
[TBL] [Abstract][Full Text] [Related]
58. Predictors of anti-VEGF efficacy in chronic central serous chorioretinopathy based on intraocular cytokine levels and pigment epithelium detachment subtypes.
Mao J; Zhang C; Zhang S; Liu C; Chen N; Tao J; She X; Zheng Z; Lv Z; Shen L
Acta Ophthalmol; 2022 Nov; 100(7):e1385-e1394. PubMed ID: 35122421
[TBL] [Abstract][Full Text] [Related]
59. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.
Çiloğlu E; Unal F; Dogan NC
Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1111-1116. PubMed ID: 29671064
[TBL] [Abstract][Full Text] [Related]
60. Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy.
Toyama T; Ohtomo K; Noda Y; Ueta T
Eye (Lond); 2014 Aug; 28(8):992-7. PubMed ID: 24924443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
